Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 6, 2013 (13 years ago)

0.9% Sodium Chloride Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: The product has the potential for solution to leak at or near the administrative port of the primary container.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

0.9% Sodium Chloride Injection, USP, 250 mL single dose Flexible Plastic Container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7983-02

Affected NDC 0409-7983-02

Compare with the code on your package — it is the most precise check available.

Recalling firm
Hospira Inc.
NDC code
0409-7983-02
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-608-2013 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Hospira Inc.

All 2013 recalls
Class II · Moderate risk

DOBUTamine Injection

Discoloration: Firm received complaints of product discoloration and particulates.

Terminated Failed specification Hospira Inc. NDC 0409-2025-20 D-1500-2016

Other sterility / contamination recalls from 2013

All sterility / contamination recalls
Class II · Moderate risk

Vitamin B-12 injections

Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.

Terminated Sterility / contamination Zions RX Formulations Services LLC dba RX Formuations Serv. D-1219-2014
Class II · Moderate risk

Bupivacaine 3%

Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.

Terminated Sterility / contamination Zions RX Formulations Services LLC dba RX Formuations Serv. D-1218-2014